NEW YORK (Reuters) - A federal appeals court decertified a class of unions and insurers that accused Eli Lilly and Co of overpricing its Zyprexa anti-psychotic drug after misrepresenting its efficacy and side effects. (Source: Reuters: Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.
Read from Source
|
